Neovasc to Report Third Quarter 2021 Financial Results on November 9, 2021
November 01 2021 - 9:05AM
via NewMediaWire –
Neovasc Inc. (NASDAQ, TSX: NVCN),
will report financial results for the quarter ended September 30,
2021 on Tuesday, November 9, 2021. Neovasc’s President and Chief
Executive Officer Fred Colen, and Chris Clark, Chief Financial
Officer, will host a conference call to review the company’s
results at 4:30 pm EDT on November 9, 2021.
Interested parties may access the conference call by dialing
(877)-407-9208 or (201)-493-6784 (International) and reference
Conference ID 13723809. Participants wishing to join the call via
webcast should use the link posted on the investor relations
section of the Neovasc website at
https://www.neovasc.com/investors/.
A replay of the webcast will be available approximately 30
minutes after the conclusion of the call using the link on the
Neovasc website.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops,
manufactures and markets products for the rapidly growing
cardiovascular marketplace. The Company is a leader in the
development of minimally invasive transcatheter mitral valve
replacement technologies, and minimally invasive devices for the
treatment of refractory angina. Its products include the Neovasc
Reducer™, for the treatment of refractory angina, which is not
currently commercially available in the United States (2 U.S.
patients have been treated under Compassionate Use) and has been
commercially available in Europe since 2015, and Tiara™, for the
transcatheter treatment of mitral valve disease, which is currently
under clinical investigation in the United States, Canada, Israel
and Europe. For more information, visit: www.neovasc.com.
InvestorsMike CavanaughWestwicke/ICR Phone:
+1.617.877.9641Mike.Cavanaugh@westwicke.com
MediaSean LeousWestwicke/ICR Phone:
+1.646.677.1839Sean.Leous@icrinc.com
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Apr 2023 to Apr 2024